Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Melanoma Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Lymph Node Excision Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Breast Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Survival Medicine & Life Sciences
Metastasectomy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1998 2019

Research Output 1993 2016

6 Citations

Association of interferon regulatory factor-4 polymorphism rs12203592 with divergent melanoma pathways

Gibbs, D. C. , Orlow, I. , Bramson, J. I. , Kanetsky, P. A. , Luo, L. , Kricker, A. , Armstrong, B. A. , Anton-Culver, H. , Gruber, S. B. , Marrett, L. D. , Gallagher, R. P. , Zanetti, R. , Rosso, S. , Dwyer, T. , Sharma, A. , La Pilla, E. , From, L. , Busam, K. J. , Cust, A. E. , Ollila, D. W. & 3 others Begg, C. B., Berwick, M. & Thomas, N. E. Jan 1 2016 In : Journal of the National Cancer Institute. 108, 7, djw004

Research output: Contribution to journalArticle

Solar System
Single Nucleotide Polymorphism
interferon regulatory factor-4
Odds Ratio
5 Citations

Breast Conservation Therapy Versus Mastectomy: Shared Decision-Making Strategies and Overcoming Decisional Conflicts in Your Patients

Margenthaler, J. A. & Ollila, D. W. Oct 1 2016 In : Annals of Surgical Oncology. 23, 10, p. 3133-3137 5 p.

Research output: Contribution to journalArticle

Segmental Mastectomy
Decision Making
7 Citations

Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma

Andtbacka, R. H. I., Agarwala, S. S., Ollila, D. W., Hallmeyer, S., Milhem, M., Amatruda, T., Nemunaitis, J. J., Harrington, K. J., Chen, L., Shilkrut, M., Ross, M. & Kaufman, H. L. Dec 1 2016 In : Head and Neck. 38, 12, p. 1752-1758 7 p.

Research output: Contribution to journalArticle

Granulocyte-Macrophage Colony-Stimulating Factor
3 Citations

Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II–III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance)

Golshan, M., Cirrincione, C. T., Sikov, W. M., Carey, L. A., Berry, D. A., Overmoyer, B., Henry, N. L., Somlo, G., Port, E., Burstein, H. J., Hudis, C., Winer, E., Ollila, D. W. & for the Alliance for Clinical Trials in Oncology, T. A. F. C. T. I. O. Nov 1 2016 In : Breast Cancer Research and Treatment. 160, 2, p. 297-304 8 p.

Research output: Contribution to journalArticle

Neoadjuvant Therapy
Breast Neoplasms

Metastasectomy for stage IV melanoma in the era of effective systemic agents

Ollila, D. W., Lopez, N. E. & Hsueh, E. C. 2016 In : Critical Reviews in Oncogenesis. 21, 1-2, p. 37-55 19 p.

Research output: Contribution to journalArticle

Pharmaceutical Preparations